Literature DB >> 32100109

Evaluation of an optimal cutoff of parathyroid venous sampling gradient for localizing primary hyperparathyroidism.

Jooyeon Lee1, Namki Hong1, Byung Moon Kim2, Dong Joon Kim2, Mijin Yun3, Jong Ju Jeong4, Yumie Rhee5.   

Abstract

INTRODUCTION: Parathyroid venous sampling (PVS) has been reported to be a useful adjunctive test in localizing lesions in elusive cases of primary hyperparathyroidism (PHPT). Conventional cutoff (twofold) is now widely being used, but optimal cutoff threshold for PVS gradient based on discriminatory performance remains unclear.
MATERIALS AND METHODS: Among a total of 197 consecutive patients (mean age 58.2 years, female 74.6%) with PHPT who underwent parathyroidectomy at a tertiary center between 2012 and 2018, we retrospectively analyzed 59 subjects who underwent PVS for persistent or recurrent disease after previous parathyroidectomy, or for equivocal or negative results from conventional imaging modalities including ultrasonography (US) and Tc99m-Sestamibi SPECT-CT (MIBI). True parathyroid lesions were confirmed by combination of surgical, pathological findings, and intraoperative parathyroid hormone (PTH) changes. Optimal PVS cutoff were determined by receiver-operating characteristics (ROC) analysis with Youden and Liu method.
RESULTS: Compared to subjects who did not require PVS, PVS group tends to have lower PTH (119.8 pg/mL vs 133.7 pg/mL, p = 0.075). A total of 79 culprit parathyroid lesions (left 40; right 39) from 59 patients (left 24; right 26; bilateral 9) were confirmed by surgery. The optimal cutoff for PVS gradient was estimated as 1.5-fold gradient (1.5 ×) with sensitivity of 61.8% and specificity of 84%. When 1.5 × cutoff was applied, PVS improved the discrimination for true parathyroid lesions substantially based on area under ROC (0.892 to 0.942, p < 0.001) when added to US and MIBI.
CONCLUSION: Our findings suggest that PVS with cutoff threshold 1.5 × can provide useful complementary information for pre-operative localization in selected cases.

Entities:  

Keywords:  Optimal cutoff; Parathyroid venous sampling; Pre-operative localization; Primary hyperparathyroidism; Threshold

Mesh:

Substances:

Year:  2020        PMID: 32100109     DOI: 10.1007/s00774-020-01085-2

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  32 in total

1.  Selective parathyroid venous sampling in patients with complicated hyperparathyroidism.

Authors:  C M Ogilvie; P L Brown; M Matson; J Dacie; R H Reznek; K Britton; R Carpenter; D Berney; W M Drake; P J Jenkins; S L Chew; J P Monson
Journal:  Eur J Endocrinol       Date:  2006-12       Impact factor: 6.664

Review 2.  The Essentials of Parathyroid Hormone Venous Sampling.

Authors:  Bedros Taslakian; Scott O Trerotola; Barry Sacks; Rahmi Oklu; Amy Deipolyi
Journal:  Cardiovasc Intervent Radiol       Date:  2016-10-28       Impact factor: 2.740

3.  Non-super-selective venous sampling for persistent hyperparathyroidism using a systemic hypocalcemic challenge.

Authors:  Lilah F Morris; Christopher Loh; Kevin Ro; James E Wiseman; Antoinette S Gomes; Amy Asandra; Samuel Wariri; Michael W Yeh
Journal:  J Vasc Interv Radiol       Date:  2012-07-24       Impact factor: 3.464

4.  Selective parathyroid venous sampling in primary hyperparathyroidism: A systematic review and meta-analysis.

Authors:  Kareem Ibraheem; Eman A Toraih; Antoine B Haddad; Mahmoud Farag; Gregory W Randolph; Emad Kandil
Journal:  Laryngoscope       Date:  2018-05-14       Impact factor: 3.325

Review 5.  Hyperparathyroidism.

Authors:  John P Bilezikian; Leonardo Bandeira; Aliya Khan; Natalie E Cusano
Journal:  Lancet       Date:  2017-09-17       Impact factor: 79.321

Review 6.  Clinical review: Parathyroid localization and implications for clinical management.

Authors:  John W Kunstman; Jonathan D Kirsch; Amit Mahajan; Robert Udelsman
Journal:  J Clin Endocrinol Metab       Date:  2013-01-23       Impact factor: 5.958

7.  Accuracy of selective venous sampling for intact parathyroid hormone in difficult patients with recurrent or persistent hyperparathyroidism.

Authors:  Julia J Jones; Laurent Brunaud; Christopher F Dowd; Quan-Yang Duh; Eugene Morita; Orlo H Clark
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

8.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Authors:  Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel Siris; Julia Udesky; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

9.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.

Authors:  John P Bilezikian; Maria Luisa Brandi; Richard Eastell; Shonni J Silverberg; Robert Udelsman; Claudio Marcocci; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

Review 10.  Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Authors:  A A Khan; D A Hanley; R Rizzoli; J Bollerslev; J E M Young; L Rejnmark; R Thakker; P D'Amour; T Paul; S Van Uum; M Zakaria Shrayyef; D Goltzman; S Kaiser; N E Cusano; R Bouillon; L Mosekilde; A W Kung; S D Rao; S K Bhadada; B L Clarke; J Liu; Q Duh; E Michael Lewiecki; F Bandeira; R Eastell; C Marcocci; S J Silverberg; R Udelsman; K Shawn Davison; J T Potts; M L Brandi; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-09-09       Impact factor: 4.507

View more
  1 in total

1.  Parathyroid venous sampling for the preoperative localisation of parathyroid adenoma in patients with primary hyperparathyroidism.

Authors:  Joon Ho; Donggyu Kim; Ji-Eun Lee; Namki Hong; Byung Moon Kim; Dong Joon Kim; Jinkyong Kim; Cho Rok Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Yumie Rhee
Journal:  Sci Rep       Date:  2022-04-29       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.